In a series of recent developments in the health sector, South African HIV vaccine trials have been halted due to U.S. aid cuts, affecting potential breakthroughs in vaccine research. The USAID’s sudden withdrawal has left labs in limbo, stalling efforts on pre-clinical tests for new vaccine formulas.
About the Author
